Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morten Andersen

Showing results (191-200 of 197) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 197 results.
Blood Cancer Journal|February 8, 2024
Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms-a Danish longitudinal studyMorten Kranker Larsen, Vibe Skov, Lasse Kjær, et al.
Journal of Internal Medicine|November 6, 2025
The JAK2V617F and CALR mutations and risk of cancer, cardiovascular diseases, and all-cause mortalityMorten Kranker Larsen, Vibe Skov, Lasse Kjær, et al.
European Journal of Haematology|September 2, 2022
Clonal haematopoiesis of indeterminate potential and impaired kidney function-A Danish general population study with 11 years follow-upMorten K Larsen, Vibe Skov, Lasse Kjaer, et al.
British Journal of Clinical Pharmacology|July 19, 2019
Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008-2015): A cross-national drug utilization studyLuisa Ibáñez, Mònica Sabaté, Xavier Vidal, et al.
Frontiers in Pharmacology|August 12, 2011
Policies to enhance prescribing efficiency in europe: findings and future implicationsBrian Godman, William Shrank, Morten Andersen, et al.
Drug Safety|June 9, 2023
Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series StudyShahab Abtahi, Romin Pajouheshnia, Carlos E Durán, et al.
Frontiers in Pharmacology|September 4, 2023
Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysisCarlos E Durán, Judit Riera-Arnau, Shahab Abtahi, et al.
Pageof 20

Showing results (191-200 of 197) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 197 results.
Blood Cancer Journal|February 8, 2024
Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms-a Danish longitudinal studyMorten Kranker Larsen, Vibe Skov, Lasse Kjær, et al.
Journal of Internal Medicine|November 6, 2025
The JAK2V617F and CALR mutations and risk of cancer, cardiovascular diseases, and all-cause mortalityMorten Kranker Larsen, Vibe Skov, Lasse Kjær, et al.
European Journal of Haematology|September 2, 2022
Clonal haematopoiesis of indeterminate potential and impaired kidney function-A Danish general population study with 11 years follow-upMorten K Larsen, Vibe Skov, Lasse Kjaer, et al.
British Journal of Clinical Pharmacology|July 19, 2019
Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008-2015): A cross-national drug utilization studyLuisa Ibáñez, Mònica Sabaté, Xavier Vidal, et al.
Frontiers in Pharmacology|August 12, 2011
Policies to enhance prescribing efficiency in europe: findings and future implicationsBrian Godman, William Shrank, Morten Andersen, et al.
Drug Safety|June 9, 2023
Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series StudyShahab Abtahi, Romin Pajouheshnia, Carlos E Durán, et al.
Frontiers in Pharmacology|September 4, 2023
Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysisCarlos E Durán, Judit Riera-Arnau, Shahab Abtahi, et al.
Pageof 20